SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
1.72
0.02 (1.18%)
At close: Jun 17, 2025, 2:39 PM

SAB Biotherapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for SABS stock have an median target of 11, with a low estimate of 10 and a high estimate of 12. The median target predicts an increase of 539.53% from the current stock price of 1.72.

Target Low Average Median High
Price 10 11 11 12
Change 481.40% 539.53% 539.53% 597.67%

Latest Analyst Insight Report

Chardan Capital has reaffirmed a Buy rating on SAB... Unlock content with Pro Subscription

Updated May 15, 2025

Rating Sep 24 Oct 24 Nov 24 Jan 25 Apr 25 May 25
Strong Buy 000000
Buy 211222
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 1 1 2 2 2

Financial Forecast this Year

Revenue This Year
300K
from 1.32M
Increased by -77.3%
Revenue Next Year
600K
from 300K
Increased by 100.0%
EPS This Year
-2.04
from -3.68
Increased by 44.6%
EPS Next Year
-1.27
from -2.04
Increased by 37.7%